U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07179237) titled 'Efficacy of Carminal in Helicobacter Pylori Gastritis' on Sept. 09.
Brief Summary: Eighty patients will be included and randomized in two groups, one group (40 patients) will be administered 30 ml of the supplement Carminal, once a day, plus therapy for HP gastitis and the control group (40 patients) will be given standard therapy for HP gastritis with placebo. Treatment will begin after complection of upper endoscopy with histology results from biopted gastric mucosa. Treatment with Carminal will be continued after successful HP eradication during 12 weeks. The final evaluation will take place 12 weeks after the last Carminal inta...